1)Kinase inhibitor激酶抑制剂
1.The feasibility of application of reverse docking method to the selectivity studies of protein kinase inhibitors探索应用反向对接技术研究蛋白激酶抑制剂选择性的可行性
2.The signal transduction pathway of multi-target kinase inhibitors as anticancer agents in clinical use or in phase Ⅲ已上市和部分正在Ⅲ期临床开发中的多靶点激酶抑制剂抑酶谱及信号传导通路分析
3.A number of diseases are linked to overactivation of protein kinases and a lot of kinase inhibitors have been developed.由于蛋白激酶的异常激活导致了许多疾病,激酶抑制剂成为当今医药领域的研究热点。
英文短句/例句
1.The anticancer role of aurora kinase inhibitorsAurora激酶抑制剂的抗肿瘤作用
2.Anticancer activity of FB2,a Src kinase inhibitor,on prostate cancerSrc激酶抑制剂FB2抗前列腺癌作用研究
3.The Mechanism of Increasing Outflow Facility by Rho-Kinase Inhibition with Y27632;Rho激酶抑制剂（Y27632）对房水流畅率的作用及其机制
4.The Experimental Study of Rho Kinase Inhibitor Y-27632 on the Mechanism of Lowering the Intraocular Pressue;Rho激酶抑制剂Y-27632降眼压机制的实验研究
5.Intraocular Pressure Lowering Effects of the Rho-kinase Inhibitor H-1152;Rho激酶抑制剂H-1152降眼压作用的实验研究
6.Design, Synthesis and Screening of CP690550 and Janus Kinase 3 Inhibitors;Jak3激酶抑制剂CP690550及其衍生物的设计、合成与筛选
7.Design, Synthesis and Screening of the Small Molecular c-Fms Kinase Inhibitors小分子c-Fms激酶抑制剂的设计、合成与筛选
8.EXPERIMENTAL STUDY ON Rho-KINASE INHIBITOR BY INTRAVENOUS INJECTION INHIBITING INTIMAL HYPERPLASIA IN VEIN GRAFTSRho激酶抑制剂对移植静脉内膜影响的实验研究
9.Advances in Relationship Between Rho-kinase Inhibitors and Heart FailureRho激酶抑制剂与心力衰竭关系的研究进展
10.Advances in the inhibitors of FLT-3 receptor tyrosine kinaseFLT-3受体酪氨酸激酶抑制剂的研究进展
11.Screening of potential small-molecular inhibitor of human Aurora-B kinase using budding yeast酵母模型在Aurora-B激酶抑制剂筛选中的应用
12.Hand-foot skin reaction by multikinase inhibitor sorafenib多激酶抑制剂索拉菲尼引起的手足皮肤反应
13.Multi-targeted protein tyrosine kinase inhibitor:research advances多靶点蛋白酪氨酸激酶抑制剂的研究进展
14.Recent Advance on p38 Mitogen-Activated Protein Kinases Inhibitorsp38丝裂原活化蛋白激酶抑制剂研究进展
15.Advances in the research of multi-target tyrosine kinase inhibitors多靶点抗肿瘤酪氨酸激酶抑制剂的研究开发
16.The Progress of Aurora Kinase and its inhibitorsAurora激酶及其抑制剂研究状态综述
17.New Advances in Aurora Kinase and Its Anti-tumor InhibitorsAurora蛋白激酶及其抑制剂的研究进展
18.Research and development of inhibitors of IκB kinase-βIκB激酶-β抑制剂的研究与开发
相关短句/例句
protein kinase inhibitor蛋白激酶抑制剂
3)multikinase inhibitor多激酶抑制剂
4)janus kinase inhibitor/AG490Janus激酶抑制剂/AG490
5)protein kinase A inhibitor蛋白激酶A抑制剂
6)Bcr-Abl tyrosine kinase inhibitorBcr-Abl激酶抑制剂
1.Pharmacology and clinical evaluation of nilotinib,a Bcr-Abl tyrosine kinase inhibitor;Bcr-Abl激酶抑制剂尼罗替尼的药理与临床评价
延伸阅读
蛋白激酶抑制剂分子式：CAS号：性质：是一类抑制蛋白激酶活性的化合物。蛋白激酶是催化蛋白质磷酸化的一组结构各不相同的酶，在基因表达的调节中起着关键的作用。蛋白激酶抑制剂根据抑制蛋白激酶的种类分为丝氨酸/苏氨酸蛋白激酶抑制剂和酪氨酸蛋白激酶抑制剂，前者又可根据作用部位，分为三组，一组作用于催化区，一组作用于调节区，另一组对调节区和催化区均有作用。
